Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06579742 · ClinicalTrials.gov registry record · NA

A Clinical Trial to Examine the Efficacy of a Supplement to Support Healthy Hair and Skin

A NA study of Hair Thinning and Hair Loss, sponsored by Scale Media.

Active
Registry status
NA
Development phase
50
Enrollment target
1
Study location

NCT06579742 is a NA study of Hair Thinning and Hair Loss that is active but no longer recruiting, run by Scale Media. The registered enrollment target is 50 participants, below the 61-participant average among 10 other Hair Thinning trials with a reported enrollment target (18% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06579742, a NA study of Hair Thinning and Hair Loss, is active but no longer recruiting, sponsored by Scale Media.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
50 participants
Enrollment target
1
Study location

Study Summary

This is a triple-blinded, randomized, placebo-controlled clinical trial designed to evaluate the efficacy of Scale Media's Live Conscious Beyond Collagen supplement on overall hair and skin health. The study will involve 50 male or female participants aged 40 and over who have self-perceived hair thinning and shedding. The trial will last for 24 weeks and includes the completion of questionnaires and photo submissions at specific time points.

Conditions Studied

Interventions

  • DIETARY_SUPPLEMENT Placebo
  • DIETARY_SUPPLEMENT Live Conscious Beyond Collagen

Study Locations (1)

California

  • Citruslabs - Santa Monica

Trial Details

FieldValue
Enrollment Target 50 participants
Start Date 2024-06-07
Est. Completion 2024-12-31
Phase NA

Sponsor

Scale Media

5 total trials

What the Registry Record Tells You About NCT06579742

The ClinicalTrials.gov registry entry for NCT06579742 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 61-participant average among 10 other Hair Thinning trials with a reported enrollment target (18% lower). The listed sponsor is Scale Media, which has 5 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Hair Thinning appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.

NCT06579742 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT06579742 about?

NCT06579742 is a clinical study titled "A Clinical Trial to Examine the Efficacy of a Supplement to Support Healthy Hair and Skin". This is a triple-blinded, randomized, placebo-controlled clinical trial designed to evaluate the efficacy of Scale Media's Live Conscious Beyond Collagen supplement on overall hair and skin health. The study will involve 50 male or female participants aged 40 and over who have self-perceived hair th...

What is the current status of trial NCT06579742?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 50 participants. The study started on 2024-06-07. Estimated completion is 2024-12-31.

What conditions does trial NCT06579742 study?

This clinical trial studies the following conditions: Hair Thinning, Hair Loss.

What interventions are being tested in trial NCT06579742?

The interventions under investigation include: Placebo (DIETARY_SUPPLEMENT), Live Conscious Beyond Collagen (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT06579742?

This trial is sponsored by Scale Media, which has 5 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06579742 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Hair Thinning

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.